Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials

BACKGROUND: Ovarian function suppression (OFS) significantly downregulates the concentration of plasma estrogens. However, it is unclear whether it offers any survival benefits if combined with adjuvant tamoxifen treatment in premenopausal women. This meta-analysis was designed to assess data from p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Shunchao, Li, Kai, Jiao, Xin, Zou, Huawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472030/
https://www.ncbi.nlm.nih.gov/pubmed/26109867
http://dx.doi.org/10.2147/OTT.S86817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472030/
https://www.ncbi.nlm.nih.gov/pubmed/26109867
http://dx.doi.org/10.2147/OTT.S86817

Ejemplares similares